Additional file 1: of Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients

Row data about clinicopathological features and clinical outcomes with omitting personally identifiable information of patients. (XLSX 27 kb)

本数据集为已剔除患者个人可识别信息（personally identifiable information）的临床病理特征（clinicopathological features）与临床结局（clinical outcomes）行数据，文件格式为XLSX，大小27 KB。